Ozempic: Key differences Here are a few key differences between the drugs: Primary indication and FDA approval Contrave The FDA has approved Contrave for long-term weight management in adults who meet specific BMI requirements: A body mass index (BMI) of 30 kg/m or higher (obesity), or A BMI of 27 kg/m or higher (overweight), plus at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol (dyslipidemia) Ozempic Ozempic is FDA-approved for: Controlling blood sugar in adults with type 2 diabetes Reducing the risk of serious heart problems, like heart attack, stroke, and death, in adults with type 2 diabetes and heart disease Reducing the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease Although Ozempic isnt FDA-approved for weight loss, your healthcare provider may prescribe it off-label to help with weight management
British Columbia health data shows that outpatient B12 test volumes increased from 267,721 to 570,265 between 2013 and 2020, which tells you people are finally waking up to B12 deficiency issues
You bear the responsibility for return shipping costs
Further reading: GLP-1 tablets vs injections Serious side effects are uncommon, but patients should know what to look out for
